Im sorry I meant ASCO not AACR, and you are probably right about AXAL being handed over to another entity and be put on the back burner. Im pretty sure the focus is now PSA, HOT and NEO.
Averaging down as I said is risky but you can never tell with this company, longs actually might have their day.